Correlation Between Lipella Pharmaceuticals and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Lipella Pharmaceuticals and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and Quoin Pharmaceuticals.
Diversification Opportunities for Lipella Pharmaceuticals and Quoin Pharmaceuticals
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lipella and Quoin is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and Quoin Pharmaceuticals
Given the investment horizon of 90 days Lipella Pharmaceuticals Common is expected to generate 2.65 times more return on investment than Quoin Pharmaceuticals. However, Lipella Pharmaceuticals is 2.65 times more volatile than Quoin Pharmaceuticals Ltd. It trades about -0.01 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.48 per unit of risk. If you would invest 330.00 in Lipella Pharmaceuticals Common on August 30, 2024 and sell it today you would lose (35.00) from holding Lipella Pharmaceuticals Common or give up 10.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| Quoin Pharmaceuticals |
Lipella Pharmaceuticals and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and Quoin Pharmaceuticals
The main advantage of trading using opposite Lipella Pharmaceuticals and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
| Quoin Pharmaceuticals vs. Ikena Oncology | Quoin Pharmaceuticals vs. Eliem Therapeutics | Quoin Pharmaceuticals vs. HCW Biologics | Quoin Pharmaceuticals vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |